SEC 13F Intelligence

Kinloch Capital, LLC / ABT

Kinloch Capital, LLC’s Abbott Laboratories Position

Does Kinloch Capital, LLC own Abbott Laboratories (ABT)? Yes — 37.7K shares worth $4M (+1.58% of its 13F portfolio) as of Q1 2026, up from 29.2K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
37.7K
% of Portfolio
+1.58%
Quarters Held
22
currently held

Position History ABT

Reported value by quarter
Q4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $2MQ3 ’21: $2MQ3 ’21Q4 ’21: $3MQ1 ’22: $3MQ2 ’22: $3MQ2 ’22Q3 ’22: $2MQ4 ’22: $2,875Q1 ’23: $2,252Q1 ’23Q2 ’23: $2MQ3 ’23: $2MQ4 ’23: $2MQ4 ’23Q1 ’24: $3MQ2 ’24: $2MQ3 ’24: $3MQ3 ’24Q4 ’24: $3MQ1 ’25: $4MQ2 ’25: $4MQ2 ’25Q3 ’25: $4MQ4 ’25: $4MQ1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202637.7K$4M+1.58%
Q4 202529.2K$4M+1.58%
Q3 202529.1K$4M+1.70%
Q2 202528.7K$4M+1.82%
Q1 202528.2K$4M+1.79%
Q4 202423.3K$3M+1.32%
Q3 202422.5K$3M+1.24%
Q2 202422.6K$2M+1.22%
Q1 202422.9K$3M+1.33%
Q4 202321.5K$2M+1.50%
Q3 202322.0K$2M+1.34%
Q2 202322.0K$2M+1.43%
Q1 202322.2K$2,252+1.32%
Q4 202226.2K$2,875+1.67%
Q3 202225.3K$2M+1.62%
Q2 202224.4K$3M+1.71%
Q1 202223.2K$3M+1.64%
Q4 202121.9K$3M+1.91%
Q3 202119.8K$2M+1.65%
Q2 202118.8K$2M+1.57%
Q1 202118.4K$2M+1.69%
Q4 202017.6K$2M+1.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kinloch Capital, LLC’s full portfolio or all institutional holders of ABT.